Immunic Inc., a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, has appointed Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer. Panzara will lead the company’s development organization, including clinical development, medical affairs, and regulatory affairs, and will be a critical partner to the Chief Executive Officer and the Board of Directors in defining and driving the overall company strategy. Panzara succeeds A...